These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33541063)

  • 1. New trends in adjunctive treatment and diagnosis in medication-related osteonecrosis of the jaw: A 10-year review.
    De Santis D; Gelpi F; Luciano U; Zarantonello M; Poscolere A; Modena N; Faccioni P; Causarano G; Finotti M; Zotti F; Magi M; Iurlaro A; Nocini PF; Alberti C; Zangani A; Capocasale G; Donadello D; Nocini R; Bernardello F
    J Biol Regul Homeost Agents; 2020; 34(6 Suppl. 2):37-48. PubMed ID: 33541063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
    Cavalcante RC; Tomasetti G
    J Craniomaxillofac Surg; 2020 Nov; 48(11):1080-1086. PubMed ID: 32998853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonate-related osteonecrosis of the jaw].
    Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
    Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: Systematic review.
    de Souza Tolentino E; de Castro TF; Michellon FC; Passoni ACC; Ortega LJA; Iwaki LCV; da Silva MC
    Head Neck; 2019 Dec; 41(12):4209-4228. PubMed ID: 31502752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current approaches for early detection and treatment of medication-related osteonecrosis of jaw].
    Janovszky Á; Vereb T; Szabó A; Piffkó J
    Orv Hetil; 2014 Dec; 155(49):1960-6. PubMed ID: 25434516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.
    Freiberger JJ; Padilla-Burgos R; McGraw T; Suliman HB; Kraft KH; Stolp BW; Moon RE; Piantadosi CA
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1573-83. PubMed ID: 22698292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw.
    Heifetz-Li JJ; Abdelsamie S; Campbell CB; Roth S; Fielding AF; Mulligan JP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Nov; 128(5):491-497.e2. PubMed ID: 31488389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB; O'Ryan F
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab as a trigger factor of medication-related osteonecrosis of the jaw. A case report.
    Javelot MJ; Sergheraert J; Agbo-Godeau S; Levy-Weil F; Laurence S; Goudot P; Khonsari RH; Mauprivez C
    J Stomatol Oral Maxillofac Surg; 2020 Jun; 121(3):300-304. PubMed ID: 31301390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review.
    Goker F; Grecchi E; Grecchi F; Francetti L; Del Fabbro M
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2662-2673. PubMed ID: 33829453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
    Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
    Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress in the treatment and prevention of medication-related osteonecrosis of the jaw].
    Xu LC; Li YF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Jul; 55(7):509-514. PubMed ID: 32634892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update MRONJ and perspectives of its treatment.
    Voss PJ; Poxleitner P; Schmelzeisen R; Stricker A; Semper-Hogg W
    J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):232-235. PubMed ID: 28697987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents.
    Rodriguez-Lozano FJ; Oñate-Sánchez RE
    Med Oral Patol Oral Cir Bucal; 2016 Sep; 21(5):e595-600. PubMed ID: 27475683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of complementary treatment with autologous platelet concentrates and/or mesenchymal stem cells in chemical osteonecrosis of the jaw. Systematic review of the literature.
    Escobedo MF; Junquera S; Gonzalez C; Vasatyuk S; Gallego L; Barbeito E; Junquera LM
    J Stomatol Oral Maxillofac Surg; 2022 Feb; 123(1):51-58. PubMed ID: 33609789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.